Last updated on August 2019

An Investigational Immuno-therapy Trial of Nivolumab or Nivolumab Plus Ipilimumab or Nivolumab Plus Platinum-doublet Chemotherapy Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)


Find a site near you

Start Over

Local Institution

Takatsuki-shi, Japan
0.6miles
  Connect »

Local Institution

Hirakata-shi, Japan
2.54miles
  Connect »